VISCOSUPPLEMENTATION MARKET ANALYSIS

Viscosupplementation Market, By Dosage (Single Injection, Three Injection, and Five Injection), By Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Mar 2024
Code : CMI197
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges: High cost of viscosupplementation therapies

The viscosupplementation market faces several challenges. Due to the high cost of viscosupplementation therapies and procedures, healthcare reimbursements pose a major difficulty. Additionally, the market has seen slower adoption rates in developing nations due to lower awareness and higher treatment expenses. Patients may also be hesitant to opt for repetitive intra-articular injections.

Market Opportunities: Growing prevalence of osteoarthritis

With rising geriatric populations worldwide, the prevalence of osteoarthritis is increasing rapidly. This growing patient pool suffering from joint pain indicates higher demand. Furthermore, ongoing research into newer viscosupplements promises treatments that are longer-lasting or require fewer injections. Expanded health coverage through insurance plans could help boost the market by facilitating access.